Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Lorcaserin for Weight Loss Maintenance
NCT02388568Completed
- Sponsor
- University of Pennsylvania
- Start
- Jan 2015
- Primary completion
- Jun 2017
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Randomised, double-blind trial in obesity comparing Lorcaserin with Placebo (2 arms). Primary endpoints: Change in Body Weight at 52 weeks and Proportion Maintaining >= 5% Loss of Initial Weight at 52 weeks. Started Jan 2015; status: completed.
02
Drugs
lorcaserin
03
Conditions
obesity
Beyond the preview
Go deeper on NCT02388568.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02388568.